Every medicine is tested on a relatively small number of people before it is approved for use by the wider population, where previously undetected reactions can emerge. Each patient is a unique medicines user with a distinctive lifestyle and circumstances. Pharmacovigilance is the process of evaluating and improving the safety of medicines. It involves collecting the data on adverse events caused due to use of medicines by patients. It plays an essential role in the early detection of drug-induced harm. DDReg helps its clients by processing and collating the safety information and adverse event data that may be required to be submitted to regulatory authorities. DDReg’s Pharmacovigilance services include.